Duration of immunotherapy in patients with advanced lung adenocarcinoma with negative driver genes: case report and literature review

Duration of immunotherapy in patients with advanced lung adenocarcinoma with negative driver genes: case report and literature review

Here, we report two cases of advanced non‐small cell lung cancer (NSCLC) in patients with negative driver genes who received ICI treatment for less than two years but continued to benefit from their administration after drug withdrawal. The first patient was diagnosed with left lung adenocarcinoma,...

Full description

Bibliographic Details
Main Authors: Qinge Shan, Haiyong Wang, Xiao Han, Jun Guo, Zhehai Wang
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Thoracic Cancer
Subjects:
Case reports
immunotherapy
NSCLC
Online Access:https://doi.org/10.1111/1759-7714.13600

Similar Items

Similar Items